Conducting rigorous assessments and obtaining the highest-quality data are essential to dermatology clinical research. Traditional clinical trial designs can pose obstacles for patients with busy work and personal lives, especially if they live far from a study site. Decentralized trials open opportunities for broader patient populations, increasingly important as competition for patients grows with the number of dermatology drugs in development.
By reducing barriers to trial access, decentralized trials can boost enrollment and retention and improve study compliance. But with assessments based largely on raters’ and patients’ visual interpretation, how do we match the rigorous standards of traditional centralized trials? This webinar will identify key points to consider when designing and planning decentralized dermatology clinical trials, including:
- Strategies to reduce the patient burden and improve engagement
- How recruiting differs between traditional and decentralized trials
- Fit-for-purpose virtual options for dermatology trials
- Advantages and disadvantages of hybrid clinical trials and fully decentralized models
We’ll also discuss reporting technologies such as photography (at home and on-site), electronic diaries, wearable biomarker devices, and mHealth.
- Stacy Weil, Senior Vice President, Clinical Informatics
- Sonja Van Wye, Executive Director, Dermatology Program Delivery